Cardiovascular Complications of Coronavirus Disease-2019 - 06/07/23

Doi : 10.1016/j.pmr.2023.03.003

Carmen M. Terzic, MD, PhD ^a,^b,^⁎ , Betsy J. Medina-Inojosa, MD ^b
^a Department of Physical Medicine and Rehabilitation, Cardiovascular Rehabilitation, Rehabilitation Medicine Research Center, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
^b Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA

^∗Corresponding author. Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905.Mayo Clinic200 First Street SouthwestRochesterMN55905

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Cardiovascular complications associated with the severe acute respiratory syndrome coronavirus 2 infection are common and lead to high mortality in the acute phase and high morbidity in the chronic phase impacting an individual's quality of life and health outcomes. Patients afflicted with coronavirus disease-2019 (COVID-19) infection display an increased risk for myocarditis, dysrhythmia, pericarditis, ischemic heart disease, heart failure, and thromboembolism. Although cardiovascular complications are reported across all patients with COVID-19, hospitalized patients with severe infection are most vulnerable. The underline pathobiology remains poorly defined albeit complex. Following current guidelines in decision-making for evaluation and management in addition to the beginning or returning exercise is recommended.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Cardiovascular complications COVID-19, Post-acute sequelae of SARS-CoV-2 infection, Cardiac, Myocarditis, Dysrhythmia, Heart failure